Jing Jin

机构：Beijing Anding Hospital · ORCID：0000-0001-6300-0364

发表论文 26 篇 · 总被引 235 次 · h-index 9

代表论文

• Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2 (2018 · Human Gene Therapy · 被引 32)
• E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer (2009 · Cancer Letters · 被引 32)
• Stability and anti-tumor effect of oncolytic herpes simplex virus type 2 (2018 · Oncotarget · 被引 29)
• Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers (2016 · Scientific Reports · 被引 26)
• The construction of a new oncolytic herpes simplex virus expressing murine interleukin‐15 with gene‐editing technology (2020 · Journal of Medical Virology · 被引 22)
• Bispecific Antibody Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells (2022 · Human Gene Therapy · 被引 16)